Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human

Renal Failure

Volumn 37, Issue 9, 2015, Pages 1498-1506

  Gutierrez Escolano A ^a   Santacruz Vazquez E ^a   Gomez Perez F ^a  

^a UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

Author keywords

Acute kidney injury; Biological markers; Contrast induced nephropathy; MicroRNAs

Indexed keywords

BIOLOGICAL MARKER; CONTRAST MEDIUM; CREATININE; LET 7A; MICRORNA; MICRORNA 146; MICRORNA 182; MICRORNA 200A; MICRORNA 200C; MICRORNA 204; MICRORNA 30A; MICRORNA 30C; MICRORNA 30E; MICRORNA 320; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMIUM BLOOD LEVEL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HUMAN; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW; ANIMAL; BLOOD; CHEMICALLY INDUCED; EARLY DIAGNOSIS; GENE EXPRESSION PROFILING; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

ACUTE KIDNEY INJURY; AGED; ANIMALS; BIOMARKERS; CONTRAST MEDIA; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RATS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE;

EID: 84944165447     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1077322     Document Type: Article

References (18)

1. Golshahi J, Nasri H, Gharipour M. Contrast-induced nephropathy: A literature review. J Nephropathol. 2014;3(2):51-56.
2. Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced nephropathy. Heart Views. 2013;14(3):106-116.
3. Matsumoto S, Sakata Y, Nakatani D, et al. A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem Biophys Res Commun. 2012; 427(2):280-284.
4. Aguado-Fraile E, Ramos E, Conde E, Rodr?guez M, Liaño F, Garc?a-Bermejo ML, . MicroRNAs in the kidney: Novel biomarkers of acute kidney injury. Nefrologia. 2013;33(6):826-834.
5. Duffield JS, Grafals M, Portilla D. MicroRNAs are potential therapeutic targets in fibrosing kidney disease: Lessons from animal models. Drug Discov Today Dis Models. 2013;10(3):e127-e135.
6. Gazi S, Altun A, Erdogan O. Contrast-induced nephropathy: Preventive and protective effects of melatonin. J Pineal Res. 2006;41(1):53-57.
7. Gao X, Gulari E, Zhou X. In situ synthesis of oligonucleotide microarrays. Biopolymers. 2004;73(5):579-596.
8. Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19(2):185-193.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-470.
10. D'Agostino Jr RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281.
11. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA. 2007; 104(9):3432-3437.
12. Zhong X, Chung AC, Chen HY, et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia. 2013;56(3):663-674.
13. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA. 2010;107(32):14339-14344.
14. Wang JF, Zha YF, Li HW, et al. Screening plasma miRNAs as biomarkers for renal ischemia-reperfusion injury in rats. Med Sci Monit. 2014;20:283-289.
15. Kanki M, Moriguchi A, Sasaki D, et al. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats. Toxicology. 2014;324:158-168.
16. He H, Li W, Qian W, et al. Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Exp Ther Med. 2014;8:1263-1266.
17. Hudzik B, Szkodzinski J, Danikiewicz A, et al. Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Eur Cytokine Netw. 2010;21(2):129-135.
18. Sui W, Yang M, Li F, et al. Serum microRNAs as new diagnostic biomarkers for pre-and post-kidney transplantation. Transplant Proc. 2014;46:3358-3362.